Polymorphic nucleic acid binding of bioactive isoquinoline alkaloids and their role in cancer

Journal of Nucleic Acids

Volumn 2010, Issue , 2010, Pages

  Maiti, Motilal ^a   Kumar, Gopinatha Suresh ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BERBERINE; CORALYNE; DNA TOPOISOMERASE; ISOQUINOLINE DERIVATIVE; NUCLEIC ACID; PALMATINE; SANGUINARINE;

ANTINEOPLASTIC ACTIVITY; CIRCULAR DICHROISM; DIFFERENTIAL SCANNING CALORIMETRY; DNA BINDING; DRUG MECHANISM; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; ISOTHERMAL TITRATION CALORIMETRY; MELTING POINT; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEIC ACID STRUCTURE; PRIORITY JOURNAL; REVIEW; SPECTROFLUOROMETRY; SPECTROPHOTOMETRY; STRUCTURE ACTIVITY RELATION; THERMAL ANALYSIS; THERMODYNAMICS; VISCOSITY;

EID: 81455123778     PISSN: 20900201     EISSN: 2090021X     Source Type: Journal    
DOI: 10.4061/2010/593408     Document Type: Review

References (194)

1. Waring M. J., DNA modification and cancer. Annual Review of Biochemistry 1981 50 159 192 2-s2.0-0019364861
2. Hurley L. H., Secondary DNA structures as molecular targets for cancer therapeutics. Biochemical Society Transactions 2001 29 6 692 696 10.1042/0300-5127:0290692 2-s2.0-0035206465 (Pubitemid 33131762)
3. Watson J. D., Crick F. H. C., Molecular structure of nucleic acids: a structure for deoxyribose nucleic acid. Nature 1953 171 4356 737 738 2-s2.0-0038497542 10.1038/171737a0
4. Belmont P., Constant J.-F., Demeunynck M., Nucleic acid conformation diversity: from structure to function and regulation. Chemical Society Reviews 2001 30 1 70 81 2-s2.0-0030476765 10.1039/a904630e (Pubitemid 33274440)
5. Blackburn G. M., Gait N. J., Nucleic Acids in Chemistry and Biology 1990 Oxford, UK IRL Press
6. Wilson W. D., chewdw@panther.gsu.edu Li K., Targeting RNA with small molecules. Current Medicinal Chemistry 2000 7 1 73 98 2-s2.0-0001548714 (Pubitemid 30395450)
7. Gallego J., Varani G., Targeting RNA with small-molecule drugs: therapeutic promise and chemical challenges. Accounts of Chemical Research 2001 34 10 836 843 10.1021/ar000118k 2-s2.0-0034783659 (Pubitemid 32999608)
8. Vicens Q., Westhof E., RNA as a drug target: the case of aminoglycosides. ChemBioChem 2003 4 10 1018 1023 10.1002/cbic.200300684 2-s2.0-0142106950 (Pubitemid 37267590)
9. Chaires J. B., Drug-Nucleic Acid Interactions 2001 New York, NY, USA Academic Press
10. Krugh T. R., Drug-DNA interactions. Current Opinion in Structural Biology 1994 4 3 351 364 10.1016/S0959-440X(94)90103-1 2-s2.0-0028284375 (Pubitemid 24195850)
11. Ihmels H., Faulhaber K., Vedaldi D., DallAcqua F., Viola G., Intercalation of organic dye molecules into double-stranded DNA - part 2: the annelated quinolizinium ion as a structural motif in DNA intercalators. Photochemistry and Photobiology 2005 81 5 1107 1115 10.1562/2005-01-25-IR-427 (Pubitemid 41545933)
12. Graves D. E., Velea L. M., Intercalative binding of small molecules to nucleic acids. Current Organic Chemistry 2000 4 9 915 929 2-s2.0-0033587654
13. Taira Z., Kanzawa S., Dohara C., Ishida S., Matsumoto M., Sakiya Y., Intercalation of six -carboline derivatives into DNA. Japanese Journal of Toxicology and Environmental Health 1997 43 2 83 91 2-s2.0-0031004838 (Pubitemid 27240517)
14. Estensen R. D., Krey A. K., Hahn F. E., Studies on a deoxyribonucleic acid-quinine complex. Molecular Pharmacology 1969 5 5 532 541 2-s2.0-0014573268
15. Maiti M., mmaiti@iicb.res.in Kumar G. S., Molecular aspects on the interaction of protoberberine, benzophenanthridine, and aristolochia group of alkaloids with nucleic acid structures and biological perspectives. Medicinal Research Reviews 2007 27 5 649 695 2-s2.0-0009711974 10.1002/med.20087 (Pubitemid 47282448)
16. Maiti M., Kumar G. S., Khan M. T. H., Protoberberine alkaloids: physicochemical and nucleic acid binding properties. Bioactive Heterocycles IV 2007 10 Berlin, Germany Springer 155 209 Topics in Heterocyclic Chemistry 10.1007/70812007071
17. Martnez R., robmar@servidor.unam.mx Chacn-García L., The search of DNA-intercalators as antitumoral drugs: what it worked and what did not work. Current Medicinal Chemistry 2005 12 2 127 151 2-s2.0-0027942883
18. Denny W. A., DNA-intercalating ligands as anti-cancer drugs: prospects for future design. Anti-Cancer Drug Design 1989 4 4 241 263 2-s2.0-0024805768 (Pubitemid 20063011)
19. Birdsall T. C., Kelly G. S., Berberine: therapeutic potential of an alkaloid found in several medicinal plants. Alternative Medicine Review 1997 2 2 94 103 2-s2.0-0002258030 (Pubitemid 127735667)
20. Verporte R., Roberts M. F., Wink M., Antimicrobially active alkaloids. Alkaloids, Biochemistry, Ecology and Medicinal Applications 1998 New York, NY, USA Plenum Press 397 433
21. Kornman K. S., Le H., Kleinman D. V., Antimicrobial agents. Dental Plaque Control Measures and Oral Hygiene Practices 1986 Oxford, UK IRL Press 121 142
22. Amin A. H., Subbaiah T. V., Abbasi K. M., Berberine sulfate: antimicrobial activity, bioassay, and mode of action. Canadian Journal of Microbiology 1969 15 9 1067 1076 2-s2.0-0014569720
23. Inoue K., Kulsum U., Chowdhury S. A., Tumor-specific cytotoxicity and apoptosis-inducing activity of berberines. Anticancer Research 2005 25 6 4053 4059 2-s2.0-27944448368 (Pubitemid 41665185)
24. Mandel I. D., Antimicrobial mouthrinses: overview and update. The Journal of the American Dental Association 1994 125 supplement 2 2S 10S 2-s2.0-0028488331
25. Ding Z., Tang S.-C., Weerasinghe P., Yang X., Pater A., Liepins A., The alkaloid sanguinarine is effective against multidrug resistance in human cervical cells via bimodal cell death. Biochemical Pharmacology 2002 63 8 1415 1421 10.1016/S0006-2952(02)00902-4 2-s2.0-0037090858 (Pubitemid 34457956)
26. Huh J., Liepins A., Zielonka J., Andrekopoulos C., Kalyanaraman B., Sorokin A., Cyclooxygenase 2 rescues LNCaP prostate cancer cells from sanguinarine-induced apoptosis by a mechanism involving inhibition of nitric oxide synthase activity. Cancer Research 2006 66 7 3726 3736 10.1158/0008-5472.CAN-05-4033 2-s2.0-33645734867
27. Bhadra K., Maiti M., Kumar G. S., gskumar@iicb.res.in Berberine-DNA complexation: new insights into the cooperative binding and energetic aspects. Biochimica et Biophysica Acta 2008 1780 9 1054 1061 2-s2.0-39449103618 10.1016/j.bbagen.2008.05.005
28. Bhadra K., Polymorphic nucleic acid structures and their interaction with isoquinoline alkaloids, Ph.D. thesis 2007 Kolkata, India Jadavpur University
29. Grycova L., Dostal J., Marek R., Quaternary protoberberine alkaloids. Phytochemistry 2007 68 2 150 175 10.1016/j.phytochem.2006.10.004 2-s2.0-33845898831 (Pubitemid 46027170)
30. Debnath D., Kumar G. S., Nandi R., Maiti M., Interaction of berberine chloride with deoxyribonucleic acids: evidence for base and sequence specificity. Indian Journal of Biochemistry and Biophysics 1989 26 4 201 208 2-s2.0-0024711354
31. Bhadra K., Maiti M., Kumar G. S., gskumar@iicb.res.in Interaction of isoquinoline alkaloid palmatine with deoxyribonucleic acids: binding heterogeneity, and conformational and thermodynamic aspects. Chemistry and Biodiversity 2008 5 4 575 590 2-s2.0-0024378717 10.1002/cbdv.200890054
32. Pal S., Kumar G. S., Debnath D., Maiti M., iichbiol@giasc101.vsnl.net.in Interaction of the antitumour alkaloid coralyne with duplex deoxyribonucleic acid structures: spectroscopic and viscometric studies. Indian Journal of Biochemistry and Biophysics 1998 35 6 321 332 2-s2.0-0025878206 (Pubitemid 128376843)
33. Maiti M., Nandi R., Chaudhuri K., Sanguinarine: a monofunctional intercalating alkaloid. FEBS Letters 1982 142 2 280 284 10.1016/0014-5793(82) 80152-X 2-s2.0-0019941688 (Pubitemid 12050509)
34. Maiti M., Nandi R., Chaudhuri K., Interaction of sanguinarine with natural and synthetic deoxyribonucleic acids. Indian Journal of Biochemistry and Biophysics 1984 21 3 158 165 2-s2.0-0021710026 (Pubitemid 15218712)
35. Michaelis L., The nature of the interaction of nucleic acids and nuclei with basic dyestuffs. Cold Spring Harbor Symposium on Quantitative Biology 1947 12 131 142
36. Maiti M., Chaudhuri K., Interaction of berberine chloride with naturally occurring deoxyribonucleic acids. Indian Journal of Biochemistry and Biophysics 1981 18 4 245 250 2-s2.0-0019835258 (Pubitemid 12106786)
37. Kumar G. S., Debnath D., Maiti M., Conformational aspects of poly(dI-dC).poly(dI-dC) and poly(dG-dC).poly(dG-dC) on binding of the alkaloid, berberine chloride. Anti-Cancer Drug Design 1992 7 4 305 314
38. Kumar G. S., Debnath D., Sen A., Maiti M., Thermodynamics of the interaction of berberine with DNA. Biochemical Pharmacology 1993 46 9 1665 1667 10.1016/0006-2952(93)90337-V 2-s2.0-0027433074 (Pubitemid 23338502)
39. Saran A., Srivastava S., Coutinho E., Maiti M., 1H NMR investigation of the interaction of berberine and sanguinarine with DNA. Indian Journal of Biochemistry and Biophysics 1995 32 2 74 77 2-s2.0-0029281557
40. Pilch D. S., pilch@rutchem.rutgers.edu Yu C., Makhey D., Minor groove-directed and intercalative ligand-DNA interactions in the poisoning of human DNA topoisomerase I by protoberberine analogs. Biochemistry 1997 36 41 12542 12553 2-s2.0-0030753506 10.1021/bi971272q (Pubitemid 27446678)
41. Chen W.-H., Chan C.-L., Cai Z., Luo G.-A., Jiang Z.-J., Study on noncovalent complexes of cytotoxic protoberberine alkaloids with double-stranded DNA by using electrospray ionization mass spectrometry. Bioorganic & Medicinal Chemistry Letters 2004 14 19 4955 4959 10.1016/j.bmcl.2004.07.037 (Pubitemid 39165602)
42. Bhadra K., Maiti M., Kumar G. S., gskumar@iicb.res.in Thermodynamics of the binding of cytotoxic protoberberine molecule coralyne to deoxyribonucleic acids. Biochimica et Biophysica Acta 2008 1780 2 298 306 2-s2.0-0017116135 10.1016/j.bbagen.2007.11.015
43. Bhadra K., Maiti M., Kumar G. S., gskumar@iicb.res.in DNA-binding cytotoxic alkaloids: comparative study of the energetics of binding of berberine, palmatine, and coralyne. DNA and Cell Biology 2008 27 12 675 685 2-s2.0-0015966032 10.1089/dna.2008.0779 (Pubitemid 352773918)
44. Li W. Y., Lu H., Xu C. X., Zhang J. B., Lu Z. H., Spectroscopic and binding properties of berberine to DNA and its application to DNA detection. Spectroscopy Letters 1998 31 6 1287 1298 10.1080/00387019808003303 (Pubitemid 128520947)
45. 2 Bioorganic and Medicinal Chemistry 2003 11 4 505 514 10.1016/S0968-0896(02)00466-2 (Pubitemid 36132227)
46. Zhu J.-J., Zhang J.-J., Zhao G.-C., Chen H.-Y., Study of interaction of berberine with DNA in the presence of -cyclodextrin. Spectroscopy Letters 1998 31 8 1705 1718 2-s2.0-0010252764 (Pubitemid 128521578)
47. Chen W.-H., cescwh@zsu.edu.cn Qin Y., Cai Z., Chan C.-L., Luo G.-A., Jiang Z.-H., zhjiang@hkbu.edu.hk Spectrometric studies of cytotoxic protoberberine alkaloids binding to double-stranded DNA. Bioorganic and Medicinal Chemistry 2005 13 5 1859 1866 2-s2.0-0034096809 10.1016/j.bmc.2004.10. 049 (Pubitemid 40215273)
48. Das S., Kumar G. S., Ray A., Maiti M., Spectroscopic and thermodynamic studies on the binding of sanguinarine and berberine to triple and double helical DNA and RNA structures. Journal of Biomolecular Structure and Dynamics 2003 20 5 703 714
49. Kumar G. S., Das S., Bhadra K., Maiti M., Protonated forms of poly[d(G-C)] and poly(dG).poly(dC) and their interaction with berberine. Bioorganic and Medicinal Chemistry 2003 11 23 4861 4870 10.1016/j.bmc.2003.09. 028 2-s2.0-0242361215 (Pubitemid 37352972)
50. Ren J., Chaires J. B., Sequence and structural selectivity of nucleic acid binding ligands. Biochemistry 1999 38 49 16067 16075 10.1021/bi992070s 2-s2.0-0033534146 (Pubitemid 129520527)
51. Maiti M., Vijayan M., Yathindra N., Kolaskar A. S., DNA triple helical structures: their interaction with aristololactam- -D-glucoside. Perspectives in Structural Biology 1999 Hyderabad, India Hyderabad University Press 583 592
52. Ray A., Kumar G. S., Das S., Maiti M., Spectroscopic studies on the interaction of aristololactam-beta-D-glucoside with DNA and RNA double and triple helices: a comparative study. Biochemistry 1999 38 19 6239 6247
53. Keppler M. D., Neidle S., Fox K. R., Stabilisation of TG- and AG-containing antiparallel DNA triplexes by triplex-binding ligands. Nucleic Acids Research 2001 29 9 1935 1942 2-s2.0-0035339967 (Pubitemid 32433278)
54. Dervan P. B., Molecular recognition of DNA by small molecules. Bioorganic and Medicinal Chemistry 2001 9 9 2215 2235 10.1016/S0968-0896(01)00262-0 2-s2.0-0034830898 (Pubitemid 32834613)
55. Polak M., Hud N. V., Complete disproportionation of duplex poly(dT).poly(dA) into triplex poly(dT).poly(dA).poly(dT) and poly(dA) by coralyne. Nucleic Acids Research 2002 30 4 983 992 2-s2.0-0034699089 (Pubitemid 34679667)
56. Bhadra K., Maiti M., Kumar G. S., Molecular recognition of DNA by small molecules: AT base pair specific intercalative binding of cytotoxic plant alkaloid palmatine. Biochimica et Biophysica Acta 2007 1770 7 1071 1080 10.1016/j.bbagen.2007.03.001 2-s2.0-34247631618 (Pubitemid 46678609)
57. Adhikari A., Hossain M., Maiti M., Kumar G. S., Energetics of the binding of phototoxic and cytotoxic plant alkaloid sanguinarine to DNA: isothermal titration calorimetric studies. Journal of Molecular Structure 2008 889 1-3 54 63 10.1016/j.molstruc.2008.01.016 2-s2.0-53149133914
58. Suhnel J., Beyond nucleic acid base pairs: from triads to heptads. Biopolymers 2002 61 1 32 51 10.1002/1097-0282(2001)61:132::AID-BIP100633.0.CO;2- B 2-s2.0-14244272146
59. Hurley L. H., dg-dna@mail.utexas.edu Wheelhouse R. T., Sun D., G-quadruplexes as targets for drug design. Pharmacology and Therapeutics 2000 85 3 141 158 2-s2.0-0024787884 10.1016/S0163-7258(99)00068-6 (Pubitemid 30160784)
60. Gornall K. C., Samosorn S., Talib J., Bremner J. B., Beck J. L., jbeck@uow.edu.au Selectivity of an indolyl berberine derivative for tetrameric G-quadruplex DNA. Rapid Communications in Mass Spectrometry 2007 21 11 1759 1766 2-s2.0-33744780994 10.1002/rcm.3019 (Pubitemid 46827212)
61. Sen D., Gilbert W., Formation of parallel four-stranded complexes by guanine-rich motifs in DNA and its implications for meiosis. Nature 1988 334 6180 364 366 2-s2.0-0023788886
62. Blackburn E. H., Structure and function of telomeres. Nature 1991 350 6319 569 573 10.1038/350569a0 2-s2.0-0025731583 (Pubitemid 21912269)
63. Rezler E. M., Bearss D. J., Hurley L. H., Telomere inhibition and telomere disruption as processes for drug targeting. Annual Review of Pharmacology and Toxicology 2003 43 359 379 10.1146/annurev.pharmtox.43.100901. 135733 2-s2.0-0037889841 (Pubitemid 37372646)
64. Karlseder J., Broccoli D., Dai Y., Hardy S., de Lange T., p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 1999 283 5406 1321 1325 10.1126/science.283.5406.1321 2-s2.0-0033605145 (Pubitemid 29108998)
65. Izbicka E., eizbicka@saci.org. Wheelhouse R. T., Raymond E., Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. Cancer Research 1999 59 3 639 644 2-s2.0-0032499210 (Pubitemid 29076062)
66. Naasani I., Seimiya H., Yamori T., Tsuruo T., FJ5002: a potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis. Cancer Research 1999 59 16 4004 4011 2-s2.0-0033566694 (Pubitemid 29393569)
67. Franceschin M., Rossetti L., DAmbrosio A., Natural and synthetic G-quadruplex interactive berberine derivatives. Bioorganic & Medicinal Chemistry Letters 2006 16 6 1707 1711 10.1016/j.bmcl.2005.12.001 2-s2.0-32044461141 (Pubitemid 43197550)
68. +-containing DNA triplexes. Biochemistry 1993 32 21 5591 5597 10.1021/bi00072a014 2-s2.0-0027318084 (Pubitemid 23178524)
69. Kluza J., Baldeyrou B., Colson P., Cytotoxicity and DNA binding properties of the plant alkaloid burasaine. European Journal of Pharmaceutical Sciences 2003 20 4-5 383 391 10.1016/j.ejps.2003.08.007 2-s2.0-0344514702 (Pubitemid 37491432)
70. Yu Y., Long C.-Y., Sun S.-Q., Liu J.-P., Application of an alkaloid as a novel fluorescence probe in the determination of DNA. Analytical Letters 2001 34 15 2659 2669 10.1081/AL-100108412 (Pubitemid 33139239)
71. Das A., Photophysical and photochemical aspects of alkaloids and their interaction with nucleic acids, Ph.D. thesis 1995 Kolkata, India Jadavpur University
72. Hossain M., Biophysical studies on the interaction of intercalating and groove binding molecules with deoxyribonucleic acids, Ph.D. thesis 2009 Kolkata, India Jadavpur University
73. Zee-Cheng K. Y., Cheng C. C., Interaction between dna and coralyne acetosulfate, an antileukemic compound. Journal of Pharmaceutical Sciences 1973 62 9 1572 1573 10.1002/jps.2600620949
74. Wilson W. D., Gough A. N., Doyle J. J., Davidson M. W., Coralyne. Intercalation with DNA as a possible mechanism of antileukemic action. Journal of Medicinal Chemistry 1976 19 10 1261 1263 10.1021/jm00232a020
75. Bhadra K., kakalibhadrars@iicb.res.in Maiti M., Kumar G. S., Interaction of isoquinoline alkaloids with polymorphic DNA structures. Chemistry and Biodiversity 2009 6 9 1323 1342 2-s2.0-0030054013 10.1002/cbdv.200900017
76. Nandi R., Debnath D., Maiti M., Interactions of berberine with poly(A) and tRNA. Biochimica et Biophysica Acta 1990 1049 3 339 342 10.1016/0167- 4781(90)90107-D 2-s2.0-0025290484 (Pubitemid 20224630)
77. Giri P., Hossain M., Kumar G. S., RNA specific molecules: cytotoxic plant alkaloid palmatine binds strongly to poly(A). Bioorganic & Medicinal Chemistry Letters 2006 16 9 2364 2368 10.1016/j.bmcl.2006.01.124 2-s2.0-33644988048
78. Giri P., Kumar G. S., Specific binding and self-structure induction to poly(A) by the cytotoxic plant alkaloid sanguinarine. Biochimica et Biophysica Acta 2007 1770 9 1419 1426 10.1016/j.bbagen.2007.05.005 2-s2.0-34547840328 (Pubitemid 47248048)
79. Giri P., Kumar G. S., gskumar@iicb.res.in Self-structure induction in single stranded poly(A) by small molecules: studies on DNA intercalators, partial intercalators and groove binding molecules. Archives of Biochemistry and Biophysics 2008 474 1 183 192 2-s2.0-0020440236 10.1016/j.abb.2008.03.013
80. Creasey W. A., Biochemical effects of berberine. Biochemical Pharmacology 1979 28 7 1081 1084 2-s2.0-0018778948 10.1016/0006-2952(79)90308-3 (Pubitemid 9186512)
81. Moraru-Allen A. A., Cassidy S., Alvarez J.-L. A., Fox K. R., Brown T., Lane A. N., a-lane@nimr.mrc.ac.uk Coralyne has a preference for intercalation between TA.T triples in intramolecular DNA triple helices. Nucleic Acids Research 1997 25 10 1890 1896 2-s2.0-0028850113 10.1093/nar/25.10.1890 (Pubitemid 27303382)
82. Jain S. S., Polak M., Hud N. V., Controlling nucleic acid secondary structure by intercalation: effects of DNA strand length on coralyne-driven duplex disproportionation. Nucleic Acids Research 2003 31 15 4608 4615 10.1093/nar/gkg648 2-s2.0-0041660898 (Pubitemid 37441820)
83. Persil O., Santai C. T., Jain S. S., Hud N. V., Assembly of an antiparallel homo-adenine DNA duplex by small-molecule binding. Journal of the American Chemical Society 2004 126 28 8644 8645 10.1021/ja0492891 2-s2.0-3242715653 (Pubitemid 38955716)
84. Nandi R., Maiti M., Binding of sanguinarine to deoxyribonucleic acids of differing base composition. Biochemical Pharmacology 1985 34 3 321 324 10.1016/0006-2952(85)90038-3 2-s2.0-0021963342 (Pubitemid 15163125)
85. Nandi R., Chaudhuri K., Maiti M., Effects of ionic strength and pH on the binding of sanguinarine to deoxyribonucleic acid. Photochemistry and Photobiology 1985 42 5 497 503 2-s2.0-0022154719
86. Maiti M., Nandi R., Circular dichroism of sanguinarine-DNA complexes: effect of base composition, pH and ionic strength. Journal of Biomolecular Structure and Dynamics 1987 5 1 159 175 2-s2.0-0023267325 (Pubitemid 17123712)
87. Sen A., Maiti M., Interaction of sanguinarine iminium and alkanolamine form with calf thymus DNA. Biochemical Pharmacology 1994 48 11 2097 2102 10.1016/0006-2952(94)90510-X 2-s2.0-0027970987 (Pubitemid 24359616)
88. Maiti M., mmaiti@iicb.res.in Das S., Sen A., Das A., Kumar G. S., Nandi R., Influence of DNA structures on the conversion of sanguinarine alkanolamine form to iminium form. Journal of Biomolecular Structure and Dynamics 2002 20 3 455 464 2-s2.0-0029047968 (Pubitemid 36019300)
89. Faddejeva M. D., Belyaeva T. N., Rosanor Yu., Sedova M., Sokolovskaya E. L., Studies on the complex formation with DNA and the effect on DNA hydrolysis, RNA synthesis and cellular membrane ATPase systems of some antitumor agants including alkaloids. Studia Biophysica 1984 104 1-3 267 269
90. Bajaj N. P., McLean M. J., Waring M. J., Smekal E., Sequence-selective, pH-dependent binding to DNA of benzophenanthridine alkaloids. Journal of Molecular Recognition 1990 3 1 48 54 2-s2.0-0025381503
91. Urbanova J., Lubal P., Slaninova I., Taborska E., Taborsky P., Fluorescence properties of selected benzo[ c ]phenantridine alkaloids and studies of their interaction with CT DNA. Analytical and Bioanalytical Chemistry 2009 394 4 997 1002 10.1007/s00216-009-2601-7 2-s2.0-67349146742
92. Smekal E., Kubova N., Kleinwatcher V., Interaction of benzophenanthridine alkaloid sanguinarine with DNA. Studia Biophysica 1984 101 125 132
93. Bai L.-P., Cai Z., Zhao Z.-Z., Nakatani K., Jiang Z.-H., zhjiang@hkbu.edu.hk Site-specific binding of chelerythrine and sanguinarine to single pyrimidine bulges in hairpin DNA. Analytical and Bioanalytical Chemistry 2008 392 4 709 716 2-s2.0-33745699196 10.1007/s00216-008-2302-7
94. Das S., Kumar G. S., Maiti M., iichbio@giascl01.vsnl.net.in Conversions of the left-handed form and the protonated form of DNA back to the bound right-handed form by sanguinarine and ethidium: a comparative study. Biophysical Chemistry 1999 76 3 199 218 2-s2.0-0020394768 10.1016/S0301-4622(98)00238-5 (Pubitemid 29080766)
95. Maiti M., Molecular aspects on the interaction of sanguinarine with B-form, Z-form and HL-form DNA structures. Indian Journal of Biochemistry and Biophysics 2001 38 1-2 20 26 2-s2.0-0035258211 (Pubitemid 33577082)
96. Latimer L. J., Payton N., Forsyth G., Lee J. S., The binding of analogues of coralyne and related heterocyclics to DNA triplexes. Biochemistry and Cell Biology 1995 73 1-2 11 18 2-s2.0-0029198606
97. Bai L. P., Hagihara M., Jiang Z. H., Nakatani K., Ligand binding to tandem G quadruplexes from human telomeric DNA. ChemBioChem 2008 9 16 2583 2587 2-s2.0-59449107619
98. Nelson P., Kiriakidou M., Sharma A., Maniataki E., Mourelatos Z., The microRNA world: small is mighty. Trends in Biochemical Sciences 2003 28 10 534 540 10.1016/j.tibs.2003.08.005 2-s2.0-0642285627 (Pubitemid 38366279)
99. Esau C. C., cesau@isisph.com Monia B. P., Therapeutic potential for microRNAs. Advanced Drug Delivery Reviews 2007 59 2-3 101 114 2-s2.0-19544390155 10.1016/j.addr.2007.03.007 (Pubitemid 46773050)
100. Takasugi M., Guendouz A., Chassignol M., Sequence-specific photo-induced cross-linking of the two strands of double-helical DNA by a psoralen covalently linked to a triple helix-forming oligonucleotide. Proceedings of the National Academy of Sciences of the United States of America 1991 88 13 5602 5606 10.1073/pnas.88.13.5602 2-s2.0-0025953701 (Pubitemid 21914793)
101. Wickens M., wickens@biochem.wisc.edu Anderson P., Jackson R. J., rjj@mole.bio.cam.ac.uk Life and death in the cytoplasm: messages from the 3′ end. Current Opinion in Genetics and Development 1997 7 2 220 232 2-s2.0-0028282443 10.1016/S0959-437X(97)80132-3 (Pubitemid 27206761)
102. Dower K., Kuperwasser N., Merrikh H., Rosbash M., A synthetic A tail rescues yeast nuclear accumulation of a ribozyme-terminated transcript. RNA 2004 10 12 1888 1899 10.1261/rna.7166704 2-s2.0-9344239333 (Pubitemid 39557826)
103. Alt F. W., Bothwell A. L. M., Knapp M., Synthesis of secreted and membrane-bound immunoglobulin Mu heavy chains is directed by mRNAs that differ at their 3′ ends. Cell 1980 20 2 293 301 2-s2.0-0018848546 (Pubitemid 10117745)
104. McDevitt M. A., Hart R. P., Wong W. W., Nevins J. R., Sequences capable of restoring poly(A) site function define two distinct downstream elements. The EMBO Journal 1986 5 11 2907 2913 2-s2.0-0022816944
105. Holcomb D. N., Tinoco I. Jr., Conformation of polyriboadenylic acid: pH and temperature dependence. Biopolymers 1965 3 2 121 133
106. Leng M., Felsenfeld G., A study of polyadenylic acid at neutral pH. Journal of Molecular Biology 1966 15 2 455 466 2-s2.0-0013879115
107. Topalian S. L., Kaneko S., Gonzales M. I., Bond G. L., Ward Y., Manley J. L., Identification and functional characterization of Neo-poly(A) polymerase, an RNA processing enzyme overexpressed in human tumors. Molecular and Cellular Biology 2001 21 16 5614 5623 10.1128/MCB.21.16.5614-5623.2001 2-s2.0-0034935020 (Pubitemid 32702464)
108. Topalian S. L., Gonzales M. I., Ward Y., Wang X., Wang R.-F., Revelation of a cryptic major histocompatibility complex class II-restricted tumor epitope in a novel RNA-processing enzyme. Cancer Research 2002 62 19 5505 5509 2-s2.0-0036791206
109. Yadav R. C., Kumar G. S., Bhadra K., Berberine, a strong polyriboadenylic acid binding plant alkaloid: spectroscopic, viscometric, and thermodynamic study. Bioorganic and Medicinal Chemistry 2005 13 1 165 174 2-s2.0-0019941688 10.1016/j.bmc.2004.09.045 (Pubitemid 39575701)
110. Xing F., Song G., Ren J., Chaires J. B., Qu X., Molecular recognition of nucleic acids: coralyne binds strongly to poly(A). FEBS Letters 2005 579 22 5035 5039 10.1016/j.febslet.2005.07.091 2-s2.0-24144502053 (Pubitemid 41242849)
111. Saenger W., Principles of Nucleic Acid Structure 1994 New York, NY, USA Springer
112. Petrovic A. G., Polavarapu P. L., Structural transitions in polyriboadenylic acid induced by the changes in pH and temperature: vibrational circular dichroism study in solution and film states. The Journal of Physical Chemistry B 2005 109 49 23698 23705 10.1021/jp054280m 2-s2.0-30544445342 (Pubitemid 43081545)
113. Zarudnaya M. I., svitlana@imbig.kiev.ua Hovorun D. M., dhovorun@imbg.org.ua Hypothetical double-helical poly(A) formation in a cell and its possible biological significance. IUBMB Life 1999 48 6 581 584 2-s2.0-0032526427 (Pubitemid 30043802)
114. Giri P., Hossain M., Kumar G. S., gskumar@iicb.res.in Molecular aspects on the specific interaction of cytotoxic plant alkaloid palmatine to poly(A). International Journal of Biological Macromolecules 2006 39 4-5 210 221 2-s2.0-19944374769 10.1016/j.ijbiomac.2006.03.026 (Pubitemid 44602208)
115. Szeto S., Yow C. M. N., Fung K. W., Characterization of berberine on human cancer cells in culture. Turkish Journal of Medical Sciences 2002 32 5 363 368 2-s2.0-0032164056 (Pubitemid 35014524)
116. Giri P., Kumar G. S., Molecular recognition of poly(A) targeting by protoberberine alkaloids: in vitro biophysical studies and biological perspectives. Molecular BioSystems. In press 10.1039/b910706a
117. Wang J. C., DNA topoisomerases: why so many? The Journal of Biological Chemistry 1991 266 11 6659 6662 2-s2.0-0025800372 (Pubitemid 21906267)
118. Berger J. M., Gamblin S. J., Harrison S. C., Wang J. C., Structure and mechanism of DNA topoisomerase II. Nature 1996 379 6562 225 232 10.1038/379225a0 2-s2.0-0030045003 (Pubitemid 26025206)
119. Roca J., Wang J. C., DNA transport by a type II DNA topoisomerase: evidence in favor of a two-gate mechanism. Cell 1994 77 4 609 616 10.1016/0092-8674(94)90222-4 2-s2.0-0028334718 (Pubitemid 24154000)
120. Champoux J. J., DNA topoisomerases: structure, function, and mechanism. Annual Review of Biochemistry 2001 70 369 413 2-s2.0-0028951482 10.1146/annurev.biochem.70.1.369 (Pubitemid 32662215)
121. Pantaziz P., Giovanella B., Rothenberg M. L., The Camptothecins: From Discovery to the Patient 1996 1 New York, NY, USA New York Academy of Sciences
122. Chen A. Y., Lin L. F., DNA topoisomerases: essential enzymes and lethal targets. Annual Review of Pharmacology and Toxicology 1994 34 191 218 10.1146/annurev.pa.34.040194.001203
123. Corbett A. H., Osheroff N., When good enzymes go bad: conversion of topoisomerase II to a cellular toxin by antineoplastic drugs. Chemical Research in Toxicology 1993 6 5 585 597 2-s2.0-0027381810 (Pubitemid 23290009)
124. Eitzen G. A., Aitchison J. D., Szilard R. K., Veenhuis M., Nuttley W. M., Rachubinski R. A., The Yarrowia lipolytica gene PAY2 encodes a 42-kDa peroxisomal integral membrane protein essential for matrix protein import and peroxisome enlargement but not for peroxisome membrane proliferation. The Journal of Biological Chemistry 1995 270 3 1429 1436 10.1074/jbc.270.3.1429 2-s2.0-0028861712
125. Covey J. M., Jaxel C., Kohn K. W., Pommier Y., Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I. Cancer Research 1989 49 5016 5022 (Pubitemid 19239335)
126. Pilch D. S., Xu Z., Sun Q., Characterizing the DNA binding modes of a topoisomerasei-poisoning terbenzimidazole: evidence for both intercalative and minor groove binding properties. Drug Design and Discovery 1996 13 3-4 115 133 2-s2.0-0026442471
127. Hsiang Y.-H., Hertzberg R., Hecht S., Liu L. F., Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. The Journal of Biological Chemistry 1985 260 27 14873 14878 2-s2.0-0022340594 (Pubitemid 16211028)
128. Hsiang Y.-H., Liu L. F., Wall M. E., DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues. Cancer Research 1989 49 16 4385 4389 2-s2.0-0024356003 (Pubitemid 19208330)
129. Bodley A., Liu L. F., Israel M., DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA. Cancer Research 1989 49 21 5969 5978 2-s2.0-0024468481 (Pubitemid 19274156)
130. Li T.-K., Bathory E., LaVoie E. J., Human topoisomerase I poisoning by protoberberines: potential roles for both drug-DNA and drug-enzyme interactions. Biochemistry 2000 39 24 7107 7116 2-s2.0-0029998477 10.1021/bi000171g (Pubitemid 30413099)
131. Krishnan P., Bastow K. F., The 9-position in berberine analogs is an important determinant of DNA topoisomerase II inhibition. Anti-Cancer Drug Design 2000 15 4 255 264 2-s2.0-0030054013 (Pubitemid 32096152)
132. Makhey D., Gatto B., Yu C., Liu A., Liu L. F., LaVoie E. J., Coralyne and related compounds as mammalian topoisomerase I and topoisomerase II poisons. Bioorganic and Medicinal Chemistry 1996 4 6 781 791 2-s2.0-0027451734 10.1016/0968-0896(96)00054-5 (Pubitemid 26202376)
133. Sanders M. M., Liu A. A., Li T.-K., Selective cytotoxicity of topoisomerase-directed protoberberines against glioblastoma cells. Biochemical Pharmacology 1998 56 9 1157 1166 10.1016/S0006-2952(98)00243-3 2-s2.0-0031772868 (Pubitemid 28511238)
134. Wang L.-K., Rogers B. D., Hecht S. M., Inhibition of topoisomerase I function by coralyne and 5,6-dihydrocoralyne. Chemical Research in Toxicology 1996 9 1 75 83 2-s2.0-0026093801
135. Holy J., jholy@d.umn.edu Lamont G., glamont@yahoo.com Perkins E., eperkins@d.umn.edu Disruption of nucleocytoplasmic trafficking of cylin DI and topoisomerase II by sanguinarine. BMC Cell Biology 2006 7, article 13 2-s2.0-0035684524 10.1186/1471-2121-7-13
136. Crowe D. L., Mechanisms of DNA damage and repair in cancer chemotherapy. Recent Research Developments in Cancer 2002 4 65 72
137. Babich H., Zuckerbraun H. L., Barber I. B., Babich S. B., Borenfreund E., Cytotoxicity of sanguinarine chloride to cultured human cells from oral tissue. Pharmacology and Toxicology 1996 78 6 397 403 2-s2.0-0022884335 (Pubitemid 26226651)
138. Bhakuni D. S., Jain S., Protoberberine alkaloids. The Alkaloids 1986 28 New York, NY, USA Academic Press 95 181
139. Suffness M., Cordel G. A., Antitumor alkaloids. The Alkaloids 1985 25 New York, NY, USA Academic Press 171 178
140. Schmeller T., Latz-Bruning B., Wink M., Biochemical activities of berberine, palmatine and sanguinarine mediating chemical defence against microorganisms and herbivores. Phytochemistry 1997 44 2 257 266 10.1016/S0031-9422(96)00545-6 2-s2.0-0342871998 (Pubitemid 27087925)
141. Simanek V., Benzophenanthridine alkaloids. The Alkaloids 1985 26 New York, NY, USA Academic Press 185 240
142. Kuo C.-L., Chi C.-W., Liu T.-Y., tyliu@vghtpe.gov.tw The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Letters 2004 203 2 127 137 2-s2.0-0018185646 10.1016/j.canlet.2003.09.002 (Pubitemid 38063132)
143. Bentley K. W., -phenylethylamines and the isoquinoline alkaloids. Natural Product Reports 2001 18 2 148 170 2-s2.0-0034058714 10.1039/a909672h (Pubitemid 32324687)
144. Nandi R., Maiti M., Chaudhuri K., Mahato S. B., Bairagi A. K., Sensitivity of vibrios to sanguinarine. Experientia 1983 39 5 524 525 2-s2.0-0020541533 (Pubitemid 13084876)
145. Koehn F. E., Carter G. T., The evolving role of natural products in drug discovery. Nature Reviews Drug Discovery 2005 4 3 206 220 10.1038/nrd1657 2-s2.0-14944383798 (Pubitemid 40372555)
146. Newman D. J., Cragg G. M., Natural products as sources of new drugs over the last 25 years. Journal of Natural Products 2007 70 3 461 477 10.1021/np068054v 2-s2.0-34247109045 (Pubitemid 46595760)
147. Anis K. V., Rajeshkumar N. V., Kuttan R., Inhibition of chemical carcinogenesis by berberine in rats and mice. Journal of Pharmacy and Pharmacology 2001 53 5 763 768 2-s2.0-0016389670 10.1211/0022357011775901 (Pubitemid 32457828)
148. Chi C.-W., Chang Y.-F., Chao T.-W., Flowcytometric analysis of the effect of Berberine on the expression of glucocorticoid receptors in human hepatoma HepG2 cells. Life Sciences 1994 54 26 2099 2107 10.1016/0024-3205(94)00719-5 (Pubitemid 24193358)
149. Kuo C. L., Chou C. C., Yung Y.-M., Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells. Cancer Letters 1995 93 2 193 200 10.1016/0304-3835(95)03809-B
150. Lin H.-L., Liu T.-Y., Wu C.-W., Chi C.-W., Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel. British Journal of Cancer 1999 81 3 416 422 10.1038/sj.bjc.6690710 2-s2.0-0032837682 (Pubitemid 29458794)
151. Kim E.-S., Yoo S.-E., Yi K. Y., Design, syntheses and biological evaluations of nonpeptidic caspase 3 inhibitors. Bulletin of the Korean Chemical Society 2002 23 7 1003 1010 2-s2.0-0000551131
152. Jantova S., Cipak L., Cernukova M., Kostalova D., Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells. Journal of Pharmacy and Pharmacology 2003 55 8 1143 1149 10.1211/002235703322277186 2-s2.0-0043026958 (Pubitemid 36998656)
153. Letasiova S., Jantova S., Hornathova M., Lakotos B., Toxicity and apoptosis induced by berberine - a potential anticancer drug. Biologia 2005 60 supplement 17 97 100 2-s2.0-33751341985 (Pubitemid 44804875)
154. Wu H. L., Hsu C. Y., Liu W. H., Yung B. Y. M., byung@mail.cgu.edu.tw Berberine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity. International Journal of Cancer 1999 81 6 923 929 2-s2.0-0023657761 10.1002/(SICI)1097- 0215(19990611)81:6923::AID-IJC143.0.CO;2-D (Pubitemid 29249978)
155. Mantena S. K., Sharma S. D., Katiyar S. K., skatiyar@uab.edu Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP. Carcinogenesis 2006 27 10 2018 2027 2-s2.0-0034807335 10.1093/carcin/bgl043 (Pubitemid 44530576)
156. Zhang R., Dougherty D. V., Rosenblum M. L., Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1- nitrosourea to treat melignant brain tumors. Chinese Medical Journal 1990 103 8 658 665 2-s2.0-0025003321 (Pubitemid 20300881)
157. Iizuka N., Miyamoto K., Okita K., Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Letters 2000 148 1 19 25 10.1016/S0304-3835(99)00264-5 2-s2.0-0033987203 (Pubitemid 30012124)
158. Serafim T. L., Oliveira P. J., Sardao V. A., Perkins E., Parke D., Holy J., jholy@d.umn.edu Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line. Cancer Chemotherapy and Pharmacology 2008 61 6 1007 1018 2-s2.0-0032553485 10.1007/s00280-007-0558-9 (Pubitemid 351423129)
159. Naasani I., inaasani@ns.jfcr.or.jp Seimiya H., Yamori T., Tsuruo T., FJ5002: a potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis. Cancer Research 1999 59 16 4004 4011 2-s2.0-0029875247 (Pubitemid 29393569)
160. Nagayama M., Sato A., Hayakawa H., Urano T., Takada Y., Takada A., Plasminogen activators and their inhibitors in non-small cell lung cancer: low content of type 2 plasminogen activator inhibitor associated with tumor dissemination. Cancer 1994 73 5 1398 1405 2-s2.0-0028325321 (Pubitemid 24072545)
161. Volm M., van Kaick G., Mattern J., Analysis of c-fos, c-jun, c-erbB1, c-erbB2 and c-myc in primary lung carcinomas and their lymph node metastases. Clinical and Experimental Metastasis 1994 12 4 329 334 10.1007/BF01753840 2-s2.0-0027936953 (Pubitemid 24257071)
162. Mitani N., Murakami K., Yamaura T., Ikeda T., Saiki I., Inhibitory effect of berberine on the mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma. Cancer Letters 2001 165 1 35 42 10.1016/S0304-3835(00)00710-2 2-s2.0-0035836778 (Pubitemid 32206655)
163. Jantova S., Cipak L., Letasiova S., Berberine induces apoptosis through a mitochondrial/caspase pathway in human promonocytic U937 cells. Toxicology in Vitro 2007 21 1 25 31 10.1016/j.tiv.2006.07.015 2-s2.0-33845219352 (Pubitemid 44855510)
164. Lin C.-C., Lin S.-Y., Chung J.-G., Lin J.-P., Chen G.-W., Kao S.-T., stkao@mail.cmu.edu.tw Down-regulation of cyclin B1 and Up-regulation of Wee1 by berberine promotes entry of leukemia cells into the G2/M-phase of the cell cycle. Anticancer Research 2006 26 2 1097 1104 2-s2.0-32144452226
165. Meeran S. M., Katiyar S., Katiyar S. K., skatiyar@uab.edu Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation. Toxicology and Applied Pharmacology 2008 229 1 33 43 2-s2.0-0027938706 10.1016/j.taap.2007.12.027
166. Hayashi K., Minoda K., Nagaoka Y., Hayashi T., Uesato S., Antiviral activity of berberine and related compounds against human cytomegalovirus. Bioorganic & Medicinal Chemistry Letters 2007 17 6 1562 1564 10.1016/j.bmcl.2006.12.085 2-s2.0-33847197936
167. Sethi M. L., Enzyme inhibition VI: inhibition of reverse transcriptase activity by protoberberine alkaloids and structure-activity relationships. Journal of Pharmaceutical Sciences 1983 72 5 538 541 10.1002/jps.2600720515 (Pubitemid 13092194)
168. DuBois R. N., Radhika A., Reddy B. S., Entingh A. J., Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 1996 110 4 1259 1262 10.1053/gast.1996.v110.pm8613017 2-s2.0-0029913633 (Pubitemid 26113767)
169. Smalley W. E., DuBois R. N., Colorectal cancer and nonsteroidal anti-inflammatory drugs. Advances in Pharmacology 1997 39 1 20 2-s2.0-0030628655
170. Fukuda K., Hibiya Y., Mutoh M., Koshiji M., Akao S., Fujiwara H., Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. Journal of Ethnopharmacology 1999 66 2 227 233 10.1016/S0378-8741(98)00162-7 2-s2.0-0032985993 (Pubitemid 29307925)
171. Chinery R., Beauchamp R. D., Shyr Y., Kirkland S. C., Coffey R. J., Morrow J. D., Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells. Cancer Research 1998 58 11 2323 2327 2-s2.0-0032101138 (Pubitemid 28252686)
172. Kosaka T., Miyata A., Ihara H., Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. European Journal of Biochemistry 1994 221 3 889 897 2-s2.0-0028226265 (Pubitemid 24146188)
173. Tsujii M., DuBois R. N., Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995 83 3 493 501 2-s2.0-0028803728
174. Niu X.-W., Zeng T., Qu A.-L., Effects of 7-bromoethoxybenzene- tetrahydropalmatine on voltage-dependent currents in guinea pig ventricular myocytes. Zhongguo Yao Li Xue Bao 1996 17 3 227 229 2-s2.0-0020376510 (Pubitemid 26163286)
175. Chang Y.-L., Usami S., Hsieh M.-T., Jiang M. J., Effects of palmatine on isometric force and intracellular calcium levels of arterial smooth muscle. Life Sciences 1999 64 8 597 606 2-s2.0-0026048788 10.1016/S0024-3205(98)00602-X (Pubitemid 29083173)
176. Phillips S. D., Castle R. N., A review of the chemistry of the antitumor benzo[ c ]phenanthridine alkaloids nitidine and fagaronine and of the related antitumor alkaloid coralyne. Journal of Heterocyclic Chemistry 1981 18 2 223 232 10.1002/jhet.5570180202 (Pubitemid 11075839)
177. Gupta R. S., Murray W., Gupta R., Cross resistance pattern towards anticancer drugs of a human carcinoma multidrug-resistant cell line. British Journal of Cancer 1988 58 4 441 447 2-s2.0-0023756352 (Pubitemid 18267796)
178. Gatto B., Sanders M. M., Yu C., Identification of topoisomerase I as the cytotoxic target of the protoberberine alkaloid coralyne. Cancer Research 1996 56 12 2795 2800 2-s2.0-0027202339 (Pubitemid 26175739)
179. Adhami V. M., Aziz M. H., Reagan-Shaw S. R., Nihal M., Mukhtar H., Ahmad N., Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin- dependent kinase machinery. Molecular Cancer Therapeutics 2004 3 8 933 940 2-s2.0-4444220152 (Pubitemid 39199588)
180. Ahmad N., Gupta S., Husain M. M., Heiskanen K. M., Mukhtar H., Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells. Clinical Cancer Research 2000 6 4 1524 1528 2-s2.0-0034005776 (Pubitemid 30226242)
181. Chmura S. J., Dolan M. E., Cha A., Mauceri H. J., Kufe D. W., Weichselbaum R. R., rrw@rover.uchicago.edu In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo. Clinical Cancer Research 2000 6 2 737 742 2-s2.0-0029895439 (Pubitemid 30111501)
182. Ishii H., Ichikawa Y.-I., Kawanabe E., Studies on the chemical constituents of rutaceous plants. LX. Development of a versatile method for syntheses of the antitumor benzo[ c ]phenanthridine alkaloids. (9). Efficient syntheses and antitumor activities of nitidine and related nonphenolic benzo[ c ]phenanthridine alkaloids. Chemical and Pharmaceutical Bulletin 1985 33 10 4139 4151 2-s2.0-0022384908 (Pubitemid 16205676)
183. Cabrespine A., Recherche.CLINIQUE@cjp.fr Bay J.-O., Barthomeuf C., Cur H., Chollet P., Debiton E., In vitro assessment of cytotoxic agent combinations for hormone-refractory prostate cancer treatment. Anti-Cancer Drugs 2005 16 4 417 422 2-s2.0-0035233927 10.1097/00001813-200504000-00008 (Pubitemid 40434608)
184. Southard G. L., Boulware R. T., Walborn D. R., Groznik W. J., Thorne E. E., Yankell S. L., Sanguinarine, a new antiplaque agent: retention and plaque specificity. The Journal of the American Dental Association 1984 108 3 338 341 2-s2.0-0021397481
185. Maiti M., Nandi R., Chaudhuri K., The effect of pH on the absorption and fluorescence spectra of sanguinarine. Journal of Photochemistry and Photobiology 1983 38 2 245 249
186. Jones R. R., Harkrader R. J., Southard G. L., The effect of pH on sanguinarine iminium ion form. Journal of Natural Products 1986 49 6 1109 1111 2-s2.0-0022884335 (Pubitemid 17041087)
187. Chaturvedi M. M., Kumar A., Darnay B. G., Chainy G. B. N., Agarwal S., Aggarwal B. B., aggarwal@utmdacc.mda.uth.tmc.edu Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF- B activation, I B phosphorylation, and degradation. The Journal of Biological Chemistry 1997 272 48 30129 30134 2-s2.0-0028167846 10.1074/jbc.272.48.30129 (Pubitemid 27512211)
188. Kaminskyy V., Lin K.-W., Filyak Y., Stoika R., stoika@cellbiol.lviv.ua Differential effect of sanguinarine, chelerythrine and chelidonine on DNA damage and cell viability in primary mouse spleen cells and mouse leukemic cells. Cell Biology International 2008 32 2 271 277 2-s2.0-0034737435 10.1016/j.cellbi. 2007.09.004 (Pubitemid 351282506)
189. Han M. H., Kim S. O., Kim G. Y., Induction of apoptosis by sanguinarine in C6 rat glioblastoma cells is associated with the modulation of the Bcl-2 family and activation of caspases through downregulation of extracellular signal-regulated kinase and Akt. Anti-Cancer Drugs 2007 18 8 913 921 2-s2.0-29444456417 10.1097/CAD.0b013e328117f463 (Pubitemid 47220710)
190. Slaninova I., Taborska E., Bochorakova H., Slanina J., Interaction of benzo[ c ]phenanthridine and protoberberine alkaloids with animal and yeast cells. Cell Biology and Toxicology 2001 17 1 51 63 10.1023/A:1010907231602 2-s2.0-0034932996 (Pubitemid 32624743)
191. Hussain A. R., Al-Jomah N. A., Siraj A. K., Sanguinarine-dependent induction of apoptosis in primary effusion lymphoma cells. Cancer Research 2007 67 8 3888 3897 10.1158/0008-5472.CAN-06-3764 2-s2.0-34248582774 (Pubitemid 46762177)
192. Larsson D. E., Lvborg H., Rickardson L., Larsson R., berg K., Granberg D., dan.granberg@medsci.uu.se Identification and evaluation of potential anti-cancer drugs on human neuroendocrine tumor cell lines. Anticancer Research 2006 26 6 4125 4129 2-s2.0-20844443105 (Pubitemid 46031481)
193. Kim S., Lee T.-J., Leem J., Choi K. S., Park J.-W., Kwon T. K., kwontk@dsmc.or.kr Sanguinarine-induced apoptosis: generation of ROS, down-regulation of Bcl-2, c-FLIP, and synergy with TRAIL. Journal of Cellular Biochemistry 2008 104 3 895 907 2-s2.0-0344858928 10.1002/jcb.21672 (Pubitemid 351830838)
194. Matkar S. S., Wrischnik L. A., Hellmann-Blumberg U., ublumberg@pacific. edu Sanguinarine causes DNA damage and p53-independent cell death in human colon cancer cell lines. Chemico-Biological Interactions 2008 172 1 63 71 2-s2.0-0034737439 10.1016/j.cbi.2007.12.006